[
    "{\"step_by_step_thinking\": \"The patient is on a combination therapy of indinavir, zidovudine, lamivudine, and ketoconazole. To determine which drug is likely to produce the adverse effects described (nephrolithiasis, hyperlipidemia, central obesity, hyperglycemia, and insulin resistance), we need to review the side effects of each drug. Indinavir is associated with nephrolithiasis, zidovudine is associated with hyperlipidemia, and ketoconazole is associated with hyperglycemia and insulin resistance. Lamivudine does not have these specific adverse effects. Therefore, the likely drug responsible for the adverse effects is Indinavir.\", \"answer_choice\": \"B\"}"
]